RLYB today
$15.65-$0.15 (-0.95%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourDescending Triangle
1 hourExpanding
15 minAscending Triangle
5 minSymmetric Triangle
Daily trend turns down below $14.21
Key levels
Resistance$16.79
Resistance$16.20
Support$15.28
Support$14.21
About Rallybio
Rallybio is a clinical-stage biotechnology company developing therapies for severe and rare diseases. Its lead candidate, RLYB116, is a subcutaneous C5 inhibitor for complement-mediated disorders, and RLYB332 is a preclinical antibody for iron overload conditions. The company also has collaborations focused on antibody discovery for rare diseases. It operates primarily in the United States.
Based on the company's 10-K filed Mar 16, 2026.
Nasdaq · Healthcare
Rallybio Corp (RLYB)
What Is the Price Target for RLYB?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is RLYB a Buy or Sell Right Now?
Thesis
- •Revenue growing 34.9% YoY with UNKNOWN trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RLYB.
Start Free Trial →Is RLYB Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG
Fair Value
$67.76
17
Moat Score
NONE
4/9
Piotroski Score
6.0
Altman Z-Score
What Is Smart Money Doing with RLYB?
Insider Signal
BUYING
14 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| MACKAY MARTIN | director | Buy | 11,607 | $88K | Nov 4, 2026 |
| MACKAY MARTIN | director | Buy | 3,562 | $8K | Nov 4, 2026 |
| MACKAY MARTIN | director | Buy | 18,055 | $80K | Nov 4, 2026 |
| HUNT RONALD | director | Buy | 14,305 | $64K | Nov 4, 2026 |
| Lieber Jonathan I | officer | Buy | 7,124 | $106K | Nov 2, 2026 |
| Lieber Jonathan I | officer | Buy | 7,875 | $117K | Oct 29, 2026 |
| Lieber Jonathan I | officer | Buy | 13,589 | $83K | Oct 29, 2026 |
| HUNT RONALD | director | Buy | 3,562 | $8K | Oct 29, 2026 |
| HUNT RONALD | director | Buy | 9,196 | $70K | Oct 29, 2026 |
| HUNT RONALD | director | Buy | 2,062 | $32K | Oct 29, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RLYB Growth Story
Revenue YoY
34.9%
3yr Revenue CAGR
N/A%
EPS Growth YoY
85.01%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for RLYB
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RLYB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:38:51 | $15.80 | 1,700 | $$27K | MIDPOINT |
| 20:38:51 | $15.80 | 1,400 | $$22K | BUY |
| 18:51:20 | $15.62 | 1,242 | $$19K | SELL |
| 17:16:44 | $15.82 | 2,000 | $$32K | BUY |
| 14:47:26 | $15.50 | 1,800 | $$28K | BUY |
5 dark pool trades shown · $$128K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Rallybio Corp (RLYB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RLYB — frequently asked questions
What is RLYB stock price today?
Rallybio Corp (RLYB) is at $15.65, down 0.95% (-$0.15) at the Nov 12, 2026 close.
Why is RLYB stock moving today?
Latest RLYB news — Nov 11, 2026: Rallybio sets a 1-for-2 share consolidation
Did RLYB beat earnings?
RLYB last reported on Aug 6, 2026: EPS -$1.09 vs -$1.28 expected — a beat of 14.8%.
Does RLYB pay a dividend?
RLYB does not currently pay a dividend.
What are RLYB support and resistance levels?
Support: $15.28, $14.21, $13.61. Resistance: $16.20, $16.79, $17.35.
What are insiders doing with RLYB?
Insider activity: BUYING, 14 buys and 1 sells in the last 90 days.
What is the latest news on RLYB?
Nov 11, 2026: Rallybio sets a 1-for-2 share consolidation